Annual Shareholders Equity
$278.51 M
+$8.20 M+3.03%
31 December 2023
Summary:
Arcturus Therapeutics Holdings annual stockholders equity is currently $278.51 million, with the most recent change of +$8.20 million (+3.03%) on 31 December 2023. During the last 3 years, it has fallen by -$118.04 million (-29.77%). ARCT annual shareholders equity is now -29.77% below its all-time high of $396.55 million, reached on 31 December 2020.ARCT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$261.87 M
+$3.28 M+1.27%
30 September 2024
Summary:
Arcturus Therapeutics Holdings quarterly stockholders equity is currently $261.87 million, with the most recent change of +$3.28 million (+1.27%) on 30 September 2024. Over the past year, it has dropped by -$18.20 million (-6.50%). ARCT quarterly shareholders equity is now -33.96% below its all-time high of $396.55 million, reached on 31 December 2020.ARCT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARCT Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.0% | -6.5% |
| 3 y3 years | -29.8% | +1.1% |
| 5 y5 years | +1941.6% | +629.5% |
ARCT Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -29.8% | +22.0% | -20.5% | +79.8% |
| 5 y | 5 years | -29.8% | +1941.6% | -34.0% | +1442.0% |
| alltime | all time | -29.8% | >+9999.0% | -34.0% | >+9999.0% |
Arcturus Therapeutics Holdings Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $261.87 M(+1.3%) |
| June 2024 | - | $258.58 M(-2.0%) |
| Mar 2024 | - | $263.97 M(-5.2%) |
| Dec 2023 | $278.51 M(+3.0%) | $278.51 M(-0.6%) |
| Sept 2023 | - | $280.06 M(-1.8%) |
| June 2023 | - | $285.18 M(-13.4%) |
| Mar 2023 | - | $329.25 M(+21.8%) |
| Dec 2022 | $270.31 M(+18.4%) | $270.31 M(+85.6%) |
| Sept 2022 | - | $145.67 M(-14.7%) |
| June 2022 | - | $170.72 M(-7.6%) |
| Mar 2022 | - | $184.75 M(-19.0%) |
| Dec 2021 | $228.21 M(-42.5%) | $228.21 M(-11.9%) |
| Sept 2021 | - | $259.13 M(-15.2%) |
| June 2021 | - | $305.65 M(-13.3%) |
| Mar 2021 | - | $352.61 M(-11.1%) |
| Dec 2020 | $396.55 M(+1437.5%) | $396.55 M(+51.6%) |
| Sept 2020 | - | $261.63 M(+180.0%) |
| June 2020 | - | $93.42 M(+450.1%) |
| Mar 2020 | - | $16.98 M(-34.2%) |
| Dec 2019 | $25.79 M(+89.1%) | $25.79 M(-28.1%) |
| Sept 2019 | - | $35.90 M(+66.0%) |
| June 2019 | - | $21.62 M(+240.2%) |
| Mar 2019 | - | $6.35 M(-53.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $13.64 M(-59.6%) | $13.64 M(-3.6%) |
| Sept 2018 | - | $14.15 M(-20.5%) |
| June 2018 | - | $17.80 M(-47.3%) |
| Dec 2017 | $33.79 M(+2042.9%) | $33.79 M(-11.7%) |
| Sept 2017 | - | $38.29 M(-5.9%) |
| June 2017 | - | $40.69 M(-8.0%) |
| Mar 2017 | - | $44.23 M(+2704.6%) |
| Dec 2016 | $1.58 M(-97.7%) | $1.58 M(-97.0%) |
| Sept 2016 | - | $52.62 M(-12.0%) |
| June 2016 | - | $59.78 M(-8.0%) |
| Mar 2016 | - | $64.99 M(-6.3%) |
| Dec 2015 | $69.33 M(+247.6%) | $69.33 M(+97.6%) |
| Sept 2015 | - | $35.08 M(-9.5%) |
| June 2015 | - | $38.76 M(+94.4%) |
| Dec 2014 | $19.94 M(-59.0%) | $19.94 M(-23.2%) |
| Sept 2014 | - | $25.96 M(-26.7%) |
| June 2014 | - | $35.42 M(-16.2%) |
| Mar 2014 | - | $42.26 M(-13.2%) |
| Dec 2013 | $48.69 M(-8686.9%) | $48.69 M(+162.8%) |
| Sept 2013 | - | $18.52 M(-13.3%) |
| June 2013 | - | $21.36 M(-3867.4%) |
| Dec 2012 | -$567.00 K(-157.6%) | -$567.00 K |
| Dec 2011 | $985.00 K | - |
FAQ
- What is Arcturus Therapeutics Holdings annual stockholders equity?
- What is the all time high annual shareholders equity for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings annual shareholders equity year-on-year change?
- What is Arcturus Therapeutics Holdings quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings quarterly shareholders equity year-on-year change?
What is Arcturus Therapeutics Holdings annual stockholders equity?
The current annual shareholders equity of ARCT is $278.51 M
What is the all time high annual shareholders equity for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high annual stockholders equity is $396.55 M
What is Arcturus Therapeutics Holdings annual shareholders equity year-on-year change?
Over the past year, ARCT annual stockholders equity has changed by +$8.20 M (+3.03%)
What is Arcturus Therapeutics Holdings quarterly stockholders equity?
The current quarterly shareholders equity of ARCT is $261.87 M
What is the all time high quarterly shareholders equity for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high quarterly stockholders equity is $396.55 M
What is Arcturus Therapeutics Holdings quarterly shareholders equity year-on-year change?
Over the past year, ARCT quarterly stockholders equity has changed by -$18.20 M (-6.50%)